Exploring autism through stem cell technology

Assistant Professor Sofia B. Lizarraga and her lab are working to translate discoveries at the bench into therapeutic treatments for autism.

The genetics behind autism

 

Sofia Lizarraga works with researchers in Brown’s Center for Translational Neuroscience to understand the underlying mechanisms that cause autism.

The development of the brain is incredibly complex. It develops in utero, but continues forming and fine-tuning connections after birth. Therefore, the intrinsic genetic programs for brain development can be influenced by the environment. These factors are important as researchers strive to develop more personalized therapies for patients with autism spectrum disorders.

One of those researchers is Sofia B. Lizarraga, Ph.D., assistant professor in the Department of Molecular Biology, Cell Biology and Biochemistry. In 2022, when the opportunity came up to move her lab from the University of South Carolina to Providence, there were many reasons to say yes. At the top of that list was Brown’s Center for Translational Neuroscience.

Lizarraga has a history with Brown, including previous work as an investigator with Eric Morrow, Mencoff Family Professor of Biology, and a long-standing collaboration with Judy Liu, Sidney A. Fox and Dorothea Doctors Fox Professor of Ophthalmology and Visual Science.

“There is an amazing group of talented researchers here that are pushing the frontiers of translational studies,” says Lizarraga. “It was really important to be in an environment where there were other researchers studying rare genetic disorders and looking at the development of the cerebral cortex—the part of our brains that really makes us who we are.”

The 'magic' of reprogramming cells

Lizarraga and her team focus much of their research on chromatin—the material that chromosomes of organisms are composed of—which consists of protein and DNA. Genetic findings suggest that there is an overrepresentation of chromatin regulatory genes that have mutations associated with autism spectrum disorders. But there’s a catch—one single chromatin regulatory gene can regulate the expression of hundreds or even thousands of other genes at the same time. Therefore, a single mutation in a chromatin regulatory gene could disrupt multiple processes that are essential for proper neuronal development. This makes it much more challenging than studying other genes.

To do their work, Lizarraga’s team harnesses the power of stem cell technology, where they take human adult cells and reprogram them (by overexpressing four transcription factors). “The re-programming process (and the quality control testing) takes about four to six months,” says Lizarraga, “but once you have the stem cells, they can become any other cell in the body. It's like magic.”

Lizarraga’s lab makes human stem cell-derived neurons in culture, which they call a two-dimensional system (cells are grown in dish as a single layer), but a future goal is the creation of three-dimensional cultures called organoids or mini brains. “Being able to have a model where you can actually mimic the early stages of human neuronal development is really powerful,” she says. “You can ask so many questions that you couldn't ask otherwise.”

“There is an amazing group of talented researchers here that are pushing the frontiers of translational studies. It was really important to be in an environment where there were other researchers studying rare genetic disorders and looking at the development of the cerebral cortex—the part of our brains that really makes us who we are.”

Sofia B. Lizarraga Assistant Professor of Molecular Biology, Cell Biology and Biochemistry
 
Sofia Lizarraga in her lab

Strength in numbers

Another great advantage to doing this work at Brown is that there are multiple labs using stem cells to study everything from Alzheimer’s disease to epilepsy and autism-related disorders. They are all asking different questions, but together they are moving the needle of discovery.

The collaboration in Brown’s Center for Translational Neuroscience is going to be really important as we move what we find at the bench to the clinic, Lizarraga says. “That is what drives me every day.”